617 related articles for article (PubMed ID: 25531348)
41. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics.
Sartor RB
Gastroenterology; 2004 May; 126(6):1620-33. PubMed ID: 15168372
[TBL] [Abstract][Full Text] [Related]
42. Probiotics.
Mizock BA
Dis Mon; 2015 Jul; 61(7):259-90. PubMed ID: 25921792
[No Abstract] [Full Text] [Related]
43. Role of Lactic Acid Probiotic Bacteria in IBD.
Vemuri R; Gundamaraju R; Eri R
Curr Pharm Des; 2017; 23(16):2352-2355. PubMed ID: 28176664
[TBL] [Abstract][Full Text] [Related]
44. Probiotics and prebiotics in Crohn's disease therapies.
Lichtenstein L; Avni-Biron I; Ben-Bassat O
Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):81-8. PubMed ID: 27048899
[TBL] [Abstract][Full Text] [Related]
45. Manipulation of the bacterial flora in inflammatory bowel disease.
Marteau P; Seksik P; Shanahan F
Best Pract Res Clin Gastroenterol; 2003 Feb; 17(1):47-61. PubMed ID: 12617882
[TBL] [Abstract][Full Text] [Related]
46. Bifidobacterium and Lactobacillus improve inflammatory bowel disease in zebrafish of different ages by regulating the intestinal mucosal barrier and microbiota.
Ni Y; Zhang Y; Zheng L; Rong N; Yang Y; Gong P; Yang Y; Siwu X; Zhang C; Zhu L; Fu Z
Life Sci; 2023 Jul; 324():121699. PubMed ID: 37061125
[TBL] [Abstract][Full Text] [Related]
47. The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review.
Lucas López R; Grande Burgos MJ; Gálvez A; Pérez Pulido R
APMIS; 2017 Jan; 125(1):3-10. PubMed ID: 27704622
[TBL] [Abstract][Full Text] [Related]
48. Probiotics for inflammatory bowel diseases: a promising adjuvant treatment.
Coqueiro AY; Raizel R; Bonvini A; Tirapegui J; Rogero MM
Int J Food Sci Nutr; 2019 Feb; 70(1):20-29. PubMed ID: 29804478
[TBL] [Abstract][Full Text] [Related]
49. Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility.
Scaldaferri F; Gerardi V; Lopetuso LR; Del Zompo F; Mangiola F; Boškoski I; Bruno G; Petito V; Laterza L; Cammarota G; Gaetani E; Sgambato A; Gasbarrini A
Biomed Res Int; 2013; 2013():435268. PubMed ID: 23991417
[TBL] [Abstract][Full Text] [Related]
50. [Fecal microbiota transplantation in treatment of inflammatory bowel diseases].
Privalov MA; Sizenko AK
Lik Sprava; 2014 Nov; (11):15-21. PubMed ID: 25528828
[TBL] [Abstract][Full Text] [Related]
51. Role of antibiotics for treatment of inflammatory bowel disease.
Nitzan O; Elias M; Peretz A; Saliba W
World J Gastroenterol; 2016 Jan; 22(3):1078-87. PubMed ID: 26811648
[TBL] [Abstract][Full Text] [Related]
52. Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives.
Roy S; Dhaneshwar S
World J Gastroenterol; 2023 Apr; 29(14):2078-2100. PubMed ID: 37122604
[TBL] [Abstract][Full Text] [Related]
53. Prebiotics, synbiotics and inflammatory bowel disease.
Steed H; Macfarlane GT; Macfarlane S
Mol Nutr Food Res; 2008 Aug; 52(8):898-905. PubMed ID: 18383235
[TBL] [Abstract][Full Text] [Related]
54. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.
Linskens RK; Huijsdens XW; Savelkoul PH; Vandenbroucke-Grauls CM; Meuwissen SG
Scand J Gastroenterol Suppl; 2001; (234):29-40. PubMed ID: 11768558
[TBL] [Abstract][Full Text] [Related]
55. Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets.
Yadav V; Varum F; Bravo R; Furrer E; Bojic D; Basit AW
Transl Res; 2016 Oct; 176():38-68. PubMed ID: 27220087
[TBL] [Abstract][Full Text] [Related]
56. A Two-Week Fecal Microbiota Transplantation Course in Pediatric Patients with Inflammatory Bowel Disease.
Karolewska-Bochenek K; Grzesiowski P; Banaszkiewicz A; Gawronska A; Kotowska M; Dziekiewicz M; Albrecht P; Radzikowski A; Lazowska-Przeorek I
Adv Exp Med Biol; 2018; 1047():81-87. PubMed ID: 29151253
[TBL] [Abstract][Full Text] [Related]
57. Do probiotics have a role in the management of inflammatory bowel disease?
Morris JD; Diamond KA; Balart LA
J La State Med Soc; 2009; 161(3):155-9. PubMed ID: 19772038
[TBL] [Abstract][Full Text] [Related]
58. Intestinal dysbiosis in inflammatory bowel disease.
Kaur N; Chen CC; Luther J; Kao JY
Gut Microbes; 2011; 2(4):211-6. PubMed ID: 21983063
[TBL] [Abstract][Full Text] [Related]
59. Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies.
Shanahan F; Quigley EM
Gastroenterology; 2014 May; 146(6):1554-63. PubMed ID: 24486051
[TBL] [Abstract][Full Text] [Related]
60. The microbiome and inflammatory bowel disease.
Glassner KL; Abraham BP; Quigley EMM
J Allergy Clin Immunol; 2020 Jan; 145(1):16-27. PubMed ID: 31910984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
